A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With Secondary Progressive Multiple Sclerosis (ASCEND in SPMS)
ClinicalTrials.gov, 12 Sep 2013
Accessed on 6 Feb 2014 from http://clinicaltrials.gov/show/NCT01416181.